Search by Drug Name or NDC

NDC 70710-1656-01 Decitabine 50 mg/20mL Details

Decitabine 50 mg/20mL

Decitabine is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DECITABINE.

MedlinePlus Drug Summary

Decitabine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Decitabine is in a class of medications called hypomethylation agents. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.

Related Packages: 70710-1656-01
Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Decitabine Injection

Product Information

NDC	70710-1656
Product ID	70710-1656_18173716-8d8a-4ae2-898f-90bc8a47e17b
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Decitabine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Decitabine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	50
Active Ingredient Units	mg/20mL
Substance Name	DECITABINE
Labeler Name	Zydus Pharmaceuticals USA Inc.
Pharmaceutical Class	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA214486
Listing Certified Through	2024-12-31

Package

NDC 70710-1656-01 (70710165601)

Pricing Information	N/A
NDC Package Code	70710-1656-1
Billing NDC	70710165601
Package	1 VIAL in 1 CARTON (70710-1656-1) / 20 mL in 1 VIAL
Marketing Start Date	2023-05-11
NDC Exclude Flag	N